High expression of ELMO3 have been linked with poor prognosis in lung cancer [42], head and neck squamous cell carcinoma [43], and laryngeal cancer [44], and we have previously shown that methylation levels of the ELMO3 promoter is inversely correlated with expression of the gene [8]. This evidence concerns the gene ELMO3 and head and neck squamous cell carcinoma.